Table 4. ORs and 95% CIs for the associations between the F2FFMR trajectories of men and cardiometabolic risk factors in 2009.
| Cardiometabolic risk factors | F2FFMR trajectory group | Model 1,OR(95%CI) | Model 2,OR(95%CI) | Model 3,OR(95%CI) | Model 4,OR(95%CI) |
|---|---|---|---|---|---|
| High TC | |||||
| Low stability | Reference | Reference | Reference | Reference | |
| High stability | 0.53(0.13,2.21) | 0.54(0.12,2.27) | 0.45(0.11,1.95) | 0.23(0.03,1.73) | |
| Increase and decrease | 1.00(0.45,2.23) | 1.01(0.45,2.27) | 0.87(0.38,2.00) | 0.82(0.35,1.93) | |
| Increasing | 1.42(0.66,3.05) | 1.43(0.66,3.06) | 1.24(0.57,2.70) | 1.06(0.46,2.42) | |
| High TG | |||||
| Low stability | Reference | Reference | Reference | Reference | |
| High stability | 1.65(0.84,3.21) | 1.96(0.99,3.88) | 1.11(0.54,2.29) | 0.82(0.36,1.85) | |
| Increase and decrease | 1.65(1.00,2.70)* | 1.87(1.13,3.10)* | 1.09(0.63,1.88) | 1.06(0.59,1.88) | |
| Increasing | 0.58(0.27,1.22) | 0.60(0.28,1.28) | 0.36(0.16,0.78) | 0.32(0.14,0.74) | |
| High LDL-C | |||||
| Low stability | Reference | Reference | Reference | Reference | |
| High stability | 0.65(0.20,2.12) | 0.66(0.20,2.17) | 0.52(0.16,1.76) | 0.50(0.14,1.71) | |
| Increase and decrease | 0.80(0.36,1.78) | 0.81(0.36,1.80) | 0.65(0.29,1.50) | 0.54(0.22,1.31) | |
| Increasing | 1.58(0.81,3.09) | 1.59(0.81,3.11) | 1.37(0.69,2.72) | 1.24(0.60,2.550 | |
| Low HDL-C | |||||
| Low stability | Reference | Reference | Reference | Reference | |
| High stability | 2.06(1.00,4.24)* | 2.37(1.13,4.94)* | 1.37(0.63,2.96) | 1.66(0.73,3.74) | |
| Increase and decrease | 1.17(0.62,2.21) | 1.29(0.68,2.44) | 0.74(0.38,1.47) | 0.69(0.33,1.43) | |
| Increasing | 1.00(0.49,2.07) | 1.04(0.51,2.14) | 0.69(0.32,1.45) | 0.57(0.24,1.35) | |
| Dyslipidemia | |||||
| Low stability | Reference | Reference | Reference | Reference | |
| High stability | 1.74(0.97,3.10) | 1.95(1.08,3.51)* | 1.17(0.62,2.19) | 1.01(0.51,2.01) | |
| Increase and decrease | 1.64(1.07,2.53)* | 1.79(1.16,2.76)* | 1.12(0.69,1.79) | 1.07(0.64,1.77) | |
| Increasing | 1.09(0.67,1.79) | 1.12(0.69,1.84) | 0.73(0.43,1.24) | 0.66(0.38,1.16) | |
| Diabetes | |||||
| Low stability | Reference | Reference | Reference | Reference | |
| High stability | 4.33(2.21,8.45)* | 3.70(1.87,7.32)* | 2.68(1.31,5.51)* | 2.72(1.25,5.92)* | |
| Increase and decrease | 3.03(1.75,5.25)* | 2.72(1.56,4.74)* | 1.90(1.04,3.46)* | 1.85(0.98,3.49) | |
| Increasing | 0.48(0.15,1.55) | 0.46(0.14,1.48) | 0.35(0.11,1.16) | 0.39(0.12,1.28) | |
| hypertension | |||||
| Low stability | Reference | Reference | Reference | Reference | |
| High stability | 3.40(1.84,6.30)* | 2.48(1.32,4.68)* | 1.53(0.79,2.96) | 1.55(0.76,3.16) | |
| Increase and decrease | 2.14(1.39,3.30)* | 1.75(1.12,2.72)* | 1.10(0.69,1.77) | 1.06(0.64,1.76) | |
| Increasing | 1.29(0.81,2.05) | 1.20(0.74,1.94) | 0.84(0.51,1.39) | 0.92(0.55,1.55) |
*P<0.05. Model 1: unadjusted; Model 2: adjusted for age in 2009; Model 3: Model 2 + body mass in 2009; Model 4: Model 3 + smoking, drinking, physical activity, location, educational level, and marital status.